TY - JOUR
T1 - Commercial spaceflight participant G-force tolerance during centrifuge-simulated suborbital flight
AU - Blue, Rebecca S.
AU - Riccitello, Jon M.
AU - Tizard, Julia
AU - Hamilton, Richard J.
AU - Vanderploeg, James M.
PY - 2012/10
Y1 - 2012/10
N2 - Introduction: Medical knowledge of the human body in microgravity and hypergravity is based upon studies of healthy individuals well-conditioned for such environments. Little data exist regarding the effects of spaceflight on untrained commercial passengers. We examined the responses of potential spaceflight participants (SFP) to centrifuge G-force exposure. Methods: There were 77 individuals (65 men, 12 women), 22-88 yr old, who underwent 6 centrifuge runs over 48 h. Day 1 consisted of two +Gz runs (peak = 3.5 +G z, run 2) and two +Gx runs (peak = 6.0 +Gx, run 4). Day 2 consisted of two runs approximating a suborbital spaceflight profile. Data included blood pressure, electrocardiogram, and postrun questionnaires regarding motion sickness, disorientation, greyout, and other symptoms. Results: Of the 77 participants, average age was 50.4 ± 12.7 yr. Average heart rate (HR) varied by sex and direction of G-exposure ( +Gz: F 150 ± 19, M 123 27; +Gx: F 135 ± 30, M 110 ± 27). Age and peak HR were inversely related (HR, 120bpm: 60.2 ± 12.2 yr, HR. 120: 47.1 ± 10.9 yr). HR during peak G-exposure for the final run was associated with post-run imbalance (no imbalance: HR 126 ± 26, imbalance: HR 145 ± 21); no other significant hemodynamic change, sex, or age variation was associated with imbalance. Age and greyout were inversely associated; there was no association between greyout and vital sign change, sex, or G-force magnitude. Baseline/pretrial mean arterial pressure (MAP) was not associated with any symptoms. Discussion: The results suggest that most individuals with well-controlled medical conditions can withstand acceleration forces involved in launch/landing profiles of commercial spaceflight vehicles. Further investigation will help refine which conditions present significant risk during suborbital flight and beyond.
AB - Introduction: Medical knowledge of the human body in microgravity and hypergravity is based upon studies of healthy individuals well-conditioned for such environments. Little data exist regarding the effects of spaceflight on untrained commercial passengers. We examined the responses of potential spaceflight participants (SFP) to centrifuge G-force exposure. Methods: There were 77 individuals (65 men, 12 women), 22-88 yr old, who underwent 6 centrifuge runs over 48 h. Day 1 consisted of two +Gz runs (peak = 3.5 +G z, run 2) and two +Gx runs (peak = 6.0 +Gx, run 4). Day 2 consisted of two runs approximating a suborbital spaceflight profile. Data included blood pressure, electrocardiogram, and postrun questionnaires regarding motion sickness, disorientation, greyout, and other symptoms. Results: Of the 77 participants, average age was 50.4 ± 12.7 yr. Average heart rate (HR) varied by sex and direction of G-exposure ( +Gz: F 150 ± 19, M 123 27; +Gx: F 135 ± 30, M 110 ± 27). Age and peak HR were inversely related (HR, 120bpm: 60.2 ± 12.2 yr, HR. 120: 47.1 ± 10.9 yr). HR during peak G-exposure for the final run was associated with post-run imbalance (no imbalance: HR 126 ± 26, imbalance: HR 145 ± 21); no other significant hemodynamic change, sex, or age variation was associated with imbalance. Age and greyout were inversely associated; there was no association between greyout and vital sign change, sex, or G-force magnitude. Baseline/pretrial mean arterial pressure (MAP) was not associated with any symptoms. Discussion: The results suggest that most individuals with well-controlled medical conditions can withstand acceleration forces involved in launch/landing profiles of commercial spaceflight vehicles. Further investigation will help refine which conditions present significant risk during suborbital flight and beyond.
KW - Age
KW - G-force
KW - Hemodynamic
KW - Hypergravity
KW - Neurovestibular imbalance
UR - http://www.scopus.com/inward/record.url?scp=84867418364&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84867418364&partnerID=8YFLogxK
U2 - 10.3357/ASEM.3351.2012
DO - 10.3357/ASEM.3351.2012
M3 - Article
C2 - 23066613
AN - SCOPUS:84867418364
SN - 0095-6562
VL - 83
SP - 929
EP - 934
JO - Aviation Space and Environmental Medicine
JF - Aviation Space and Environmental Medicine
IS - 10
ER -